“Immunology and Innate Immunity are Keys to Cancer Treatment” Conclusions of the Roundtable of internationally renowned speakers, including winners of the 2011 Nobel Prize in Medicine
Innate Pharma announces its revenue for the first quarter of 2012 and updates on its cash position
World Leading Innate Immunity Specialists to Convene for Roundtable Discussion: "Innate immunity: from revolutionary discovery to revolution in therapy" - May 15, 2012, in Paris
2011 full year results: a year of momentum for Innate Pharma
Innate pharma reports higher annual revenue in 2011
Novel immune regulation mechanism involving Natural Killer Cells described and published in "Science" magazine by a key academic partner of Innate Pharma
Half-year report on Innate Pharma's liquidity contract with Natixis Securities
Innate Pharma announces its financial calendar for 2012 as well as its participations to upcoming investor conferences
Innate Pharma SA announces its participation in Actionaria on November 18 & 19 in Paris
Innate Pharma announces its turnover for the first nine months of 2011 and updates on its cash position
